Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02896517

Support for the Rhabdomyolysis in an Emergency Department

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Fondation Hôpital Saint-Joseph · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Rhabdomyolysis is a common condition in the UAA. Support is heterogeneous, it is in most cases a mass hyperhydration. The idea is to initially with an EPP simultaneously screened for the most affected by this disease and aggravating factors population, associated comorbidities. The rhabdomyolysis prognosis depends mainly on the etiology and associated comorbidities. * Acute renal failure and hyperkalemia are the major complications that worsen the prognosis. * In most cases, acute renal failure is reversible. Acute renal failure caused by renal vasoconstriction with ischemia, precipitation of myoglobin in the tubules and direct cytotoxic action of myoglobin. If the prime mover of rhabdomyolysis is ischemia (or hypoxia) cell, we now know that the tissue damage is greatly aggravated during muscle reperfusion, creating ischemia-reperfusion. Reperfusion will not only cause the release into the bloodstream of the cell contents myocytes but also an increase in necrotic areas. Indeed, the massive arrival of oxygen at the myocyte will cause significant production of free radicals, increasing their toxic effects. Predictive factors of acute renal failure is creatinine and urea. The urine alkalinisation by bicarbonates is questionable oral alkalizing seems to be an alternative when possible (oral alkaline solution) but not used to this day. The track N-acetyl cysteine as an antioxidant that can possibly have an effect on release of the free radicals during reperfusion by decreasing their toxicity is still not considered clinically.

Detailed description

Main objective / secondary: Evaluation of current professional practice: I. Identify the most common etiologies encountered in our SAU. II. Identify the / types of people most affected by this disease III. Detect the most common complications of H0 support and evolution H48 if the patient not transferred IV. Evaluate the emergency treatment at the initial charge. Methodology : DESIGN: It is a non-interventional retrospective single-center study, within the Department of Emergency GHPSJ, to an EPP and output the results regarding the type of population most affected by this disease with the most common etiologies in our support (what we are doing). Time study: Study on patient records being passed on to the emergency 12 months out with a diagnosis of rhabdomyolysis.

Conditions

Timeline

Start date
2016-10-01
Primary completion
2016-10-01
Completion
2016-10-01
First posted
2016-09-12
Last updated
2018-08-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02896517. Inclusion in this directory is not an endorsement.